Research map: Pharmacokinetics at Different Application Sites and Dermal Safety Analysis of Dextroamphetamine Transdermal System (d-ATS) in Healthy Adults and Patients with ADHD

Back to the article

Papers in this map

  1. Diagnostic and Statistical Manual of Mental Disorders · 2022 · 23135 citations · Cited by this paper
  2. Factors Associated with Favorable One-Year Outcomes After PreserFlo MicroShunt Implantation: Insights from Anterior Segment Optical Coherence Tomography · 2026 · Related
  3. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents · Mark L. Wolraich · 2019 · 1399 citations · Cited by this paper
  4. Uncontrolled Hypertension Prevalence, Characteristic Profiles, and Risk of Cardiorenal and Metabolic Outcomes: Insights from the EnligHTN Study · 2026 · Related
  5. Prevalence of Parent-Reported ADHD Diagnosis and Associated Treatment Among U.S. Children and Adolescents, 2016 · Melissa L. Danielson · 2018 · 1202 citations · Cited by this paper
  6. Diagnostic Delay in Multiple Sclerosis in China: A Nationwide Cross-Sectional Study · 2026 · Related
  7. The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis · Peige Song · 2021 · 899 citations · Cited by this paper
  8. Usability and Acceptance of Autoinjector and Prefilled Syringe Devices by Patients with Generalized Myasthenia Gravis in a Human Factors Study · 2026 · Related
  9. The global prevalence of ADHD in children and adolescents: a systematic review and meta-analysis · Nader Salari · 2023 · 659 citations · Cited by this paper
  10. Assessment of the MFSAF v4.0 and PROMIS Fatigue 7a to Measure Outcomes in Myelofibrosis: Validation from a Non-interventional Mixed Methods Study · 2026 · Related
  11. The global prevalence of attention deficit hyperactivity disorder in children and adolescents: An umbrella review of meta-analyses · Getinet Ayano · 2023 · 450 citations · Cited by this paper
  12. Long-Term Effects of Exercise During Pregnancy on the Metabolic Health of Mothers with Overweight/Obesity and Their Offspring: An 8- to 10-Year Follow-Up Study · 2026 · Related
  13. Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder · Samuele Cortese · 2020 · 346 citations · Cited by this paper
  14. Expert Consensus on the Clinical Application of Sulodexide in Vascular Diseases · 2026 · Related
  15. Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity · Margaret H. Sibley · 2016 · 270 citations · Cited by this paper
  16. An Eight-Century Evolution of Asthma Therapeutics in Western Countries: From Medieval Regimens to Anti-inflammatory Reliever Therapy and Precision Biologics · 2026 · Related
  17. ADHD in children and youth: Part 1—Etiology, diagnosis, and comorbidity · Stacey A Bélanger · 2018 · 132 citations · Cited by this paper
  18. Budget Impact of Eplerenone for Heart Failure with Reduced Ejection Fraction: National Perspective and Regional Implications in Italy · 2026 · Related
  19. Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity · Michael Huß · 2017 · 105 citations · Cited by this paper
  20. Obstetric and Neonatal Factors Associated with Postpartum Depressive Symptoms: A Retrospective Multicenter EPDS-Based Study · 2026 · Related
  21. Skin tolerability associated with transdermal drug delivery systems: an overview · Iris S. Ale · 2009 · 92 citations · Cited by this paper
  22. Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults — National Center for Health Statistics Rapid Surveys System, United States, October–November 2023 · Brooke S. Staley · 2024 · 85 citations · Cited by this paper
  23. A critical appraisal of atomoxetine in the management of ADHD · Ann Catherine Childress · 2015 · 64 citations · Cited by this paper
  24. Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects · Patrick C. Dolder · 2017 · 57 citations · Cited by this paper
  25. Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment · Xiaosu Fu · 2025 · 47 citations · Cited by this paper
  26. A clinician’s guide to ADHD treatment options · Gregory W. Mattingly · 2017 · 46 citations · Cited by this paper
  27. Patches · Leslie Citrome · 2019 · 46 citations · Cited by this paper
  28. Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS) · Robert L. Findling · 2014 · 36 citations · Cited by this paper
  29. Addressing Diagnosis and Treatment Gaps in Adults With Attention-Deficit/Hyperactivity Disorder · Rakesh Jain · 2017 · 36 citations · Cited by this paper
  30. Assessment of Transdermal Buprenorphine Patches for the Treatment of Chronic Pain in a UK Observational Study · Mick G. Serpell · 2015 · 24 citations · Cited by this paper
  31. Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease · Gus Alva · 2015 · 22 citations · Cited by this paper
  32. Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study · Andrew J. Cutler · 2022 · 20 citations · Cited by this paper
  33. Treatment patterns among children and adolescents with attention-deficit/hyperactivity disorder in the United States – a retrospective claims analysis · Jeff R. Schein · 2022 · 20 citations · Cited by this paper
  34. The Use of Transdermal Therapeutic Systems in Psychiatric Care: A Primer on Patches · Jonathan R. Stevens · 2015 · 15 citations · Cited by this paper
  35. Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology · Christopher T. Smith · 2016 · 13 citations · Cited by this paper
  36. Pharmacokinetics of AR19, an Immediate-Release Amphetamine Sulfate Formulation Designed to Deter Manipulation for Administration Via Nonoral Routes: Bioequivalence to Reference Racemic Amphetamine Sulfate, Dose Proportionality, and Food Effect · Steven Caras · 2019 · 6 citations · Cited by this paper
  37. A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers · Marwan Noel Sabbagh · 2023 · 6 citations · Cited by this paper
  38. Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension · Antonio Pardo · 2020 · 5 citations · Cited by this paper
  39. Systematic review of transdermal treatment options in attention-deficit/hyperactivity disorder: implications for use in adult patients · Christoph Ulrich Correll · 2021 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)